|
Market Closed -
NYSE
21:00:00 01/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 20.35 USD | -3.14% |
|
-9.15% | -34.35% |
| 08-14 | Oppenheimer Adjusts Pelthos Therapeutics PT to $64 From $66, Maintains Outperform Rating | MT |
| 08-13 | Pelthos Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 77.91M 69.2M 64.71M 58.97M 111M 7.5B 113M 783M 303M 3.82B 293M 286M 12.27B | P/E 2026 * |
-1.19x | P/E 2027 * | -7.23x |
|---|---|---|---|---|---|
| Enterprise Value | 77.91M 69.2M 64.71M 58.97M 111M 7.5B 113M 783M 303M 3.82B 293M 286M 12.27B | EV / Sales 2026 * |
1.22x | EV / Sales 2027 * | 0.69x |
| Free-Float |
49.9% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PTHS | Delayed | |
CBOE
| PTHS | Real-time |
Last Transcript: Pelthos Therapeutics Inc.
| 1 day | -3.14% | ||
| 1 week | -9.15% | ||
| Current month | -3.14% | ||
| 1 month | -18.01% | ||
| 3 months | -27.32% | ||
| 6 months | -4.46% | ||
| Current year | -34.35% |
| 1 week | 20.16 | 22.9 | |
| 1 month | 18.2 | 25.6 | |
| Current year | 18.19 | 30.99 | |
| 1 year | 18.19 | 37.5 | |
| 3 years | 4.5 | 60 | |
| 5 years | 4.5 | 60 | |
| 10 years | 4.5 | 60 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/07/26 | Sell | Director | -558 | 0.0161% | ||
| 02/07/26 | Sell | Director | -786 | 0.0226% | ||
| 02/07/26 | Sell | Chairman | -797 | 0.0229% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.14% | -9.15% | -24.63% | - | 80.44M | ||
| -0.62% | -2.71% | +39.30% | +114.07% | 1,031B | ||
| -2.30% | -4.44% | +39.03% | +66.07% | 638B | ||
| -0.63% | -1.96% | +6.36% | +74.38% | 462B | ||
| -1.03% | -2.82% | +59.56% | +39.69% | 359B | ||
| -0.03% | -3.96% | +23.63% | +39.35% | 335B | ||
| -1.58% | -0.76% | +13.50% | +25.77% | 273B | ||
| -2.02% | -2.97% | -3.25% | +8.38% | 253B | ||
| -3.38% | +0.30% | +36.44% | +51.54% | 228B | ||
| -1.04% | -1.46% | +32.70% | +96.82% | 185B | ||
| Average | -1.58% | -2.49% | +22.26% | +57.34% | 376.39B | |
| Weighted average by Cap. | -1.25% | -1.89% | +30.51% | +69.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.75M 56.62M 52.95M 48.25M 90.84M 6.14B 92.09M 641M 248M 3.13B 239M 234M 10.04B | 112M 99.67M 93.21M 84.94M 160M 10.8B 162M 1.13B 437M 5.5B 421M 412M 17.67B |
| Net income | -62.08M -55.14M -51.57M -46.99M -88.47M -5.98B -89.68M -624M -241M -3.04B -233M -228M -9.78B | -24.96M -22.17M -20.73M -18.89M -35.56M -2.4B -36.05M -251M -97.08M -1.22B -93.7M -91.67M -3.93B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | US$20.35 | -3.14% | 44,590 |
| 30/09/26 | US$21.01 | +0.43% | 5,453 |
| 29/09/26 | US$20.92 | -1.55% | 9,445 |
| 28/09/26 | US$21.25 | -4.24% | 12,007 |
| 25/09/26 | US$22.19 | -0.94% | 14,850 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTHS Stock
Select your edition
All financial news and data tailored to specific country editions

















